257 related articles for article (PubMed ID: 24882720)
1. Novel therapeutic approaches for celiac disease.
Vanga RR; Kelly CP
Discov Med; 2014 May; 17(95):285-93. PubMed ID: 24882720
[TBL] [Abstract][Full Text] [Related]
2. Potential therapeutic options for celiac Disease: An update on Current evidence from Gluten-Free diet to cell therapy.
Noori E; Hashemi N; Rezaee D; Maleki R; Shams F; Kazemi B; Bandepour M; Rahimi F
Int Immunopharmacol; 2024 May; 133():112020. PubMed ID: 38608449
[TBL] [Abstract][Full Text] [Related]
3. Celiac disease 2015 update: new therapies.
Veeraraghavan G; Leffler DA; Kaswala DH; Mukherjee R
Expert Rev Gastroenterol Hepatol; 2015 Jul; 9(7):913-27. PubMed ID: 25864708
[TBL] [Abstract][Full Text] [Related]
4. Supplementation of Reduced Gluten Barley Diet with Oral Prolyl Endopeptidase Effectively Abrogates Enteropathy-Associated Changes in Gluten-Sensitive Macaques.
Sestak K; Thwin H; Dufour J; Liu DX; Alvarez X; Laine D; Clarke A; Doyle A; Aye PP; Blanchard J; Moehs CP
Nutrients; 2016 Jun; 8(7):. PubMed ID: 27367722
[TBL] [Abstract][Full Text] [Related]
5. Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients.
Comino I; Fernández-Bañares F; Esteve M; Ortigosa L; Castillejo G; Fambuena B; Ribes-Koninckx C; Sierra C; Rodríguez-Herrera A; Salazar JC; Caunedo Á; Marugán-Miguelsanz JM; Garrote JA; Vivas S; Lo Iacono O; Nuñez A; Vaquero L; Vegas AM; Crespo L; Fernández-Salazar L; Arranz E; Jiménez-García VA; Antonio Montes-Cano M; Espín B; Galera A; Valverde J; Girón FJ; Bolonio M; Millán A; Cerezo FM; Guajardo C; Alberto JR; Rosinach M; Segura V; León F; Marinich J; Muñoz-Suano A; Romero-Gómez M; Cebolla Á; Sousa C
Am J Gastroenterol; 2016 Oct; 111(10):1456-1465. PubMed ID: 27644734
[TBL] [Abstract][Full Text] [Related]
6. The immunopathogenesis of celiac disease reveals possible therapies beyond the gluten-free diet.
McAllister CS; Kagnoff MF
Semin Immunopathol; 2012 Jul; 34(4):581-600. PubMed ID: 22674144
[TBL] [Abstract][Full Text] [Related]
7. Celiac disease: from pathogenesis to novel therapies.
Schuppan D; Junker Y; Barisani D
Gastroenterology; 2009 Dec; 137(6):1912-33. PubMed ID: 19766641
[TBL] [Abstract][Full Text] [Related]
8. Celiac disease: prevention and treatment.
Selimoğlu MA; Karabiber H
J Clin Gastroenterol; 2010 Jan; 44(1):4-8. PubMed ID: 20027009
[TBL] [Abstract][Full Text] [Related]
9. Gluten Degrading Enzymes for Treatment of Celiac Disease.
Wei G; Helmerhorst EJ; Darwish G; Blumenkranz G; Schuppan D
Nutrients; 2020 Jul; 12(7):. PubMed ID: 32679754
[TBL] [Abstract][Full Text] [Related]
10. Celiac disease: Hope for new treatments beyond a gluten-free diet.
D'heedene M; Vanuytsel T; Wauters L
Clin Nutr; 2024 Jun; 43(6):1240-1249. PubMed ID: 38648685
[TBL] [Abstract][Full Text] [Related]
11. Physiopathology and Management of Gluten-Induced Celiac Disease.
Kumar J; Kumar M; Pandey R; Chauhan NS
J Food Sci; 2017 Feb; 82(2):270-277. PubMed ID: 28140462
[TBL] [Abstract][Full Text] [Related]
12. Are xenogeneic anti-tissue transglutaminase antibodies the holy grail for celiac patients?
Ivanovski PI; Ivanovski IP; Sedlarevic R
Med Hypotheses; 2007; 69(6):1257-60. PubMed ID: 17553630
[TBL] [Abstract][Full Text] [Related]
13. Plasma Cells Are the Most Abundant Gluten Peptide MHC-expressing Cells in Inflamed Intestinal Tissues From Patients With Celiac Disease.
Høydahl LS; Richter L; Frick R; Snir O; Gunnarsen KS; Landsverk OJB; Iversen R; Jeliazkov JR; Gray JJ; Bergseng E; Foss S; Qiao SW; Lundin KEA; Jahnsen J; Jahnsen FL; Sandlie I; Sollid LM; Løset GÅ
Gastroenterology; 2019 Apr; 156(5):1428-1439.e10. PubMed ID: 30593798
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological approaches in celiac disease.
McCarville JL; Caminero A; Verdu EF
Curr Opin Pharmacol; 2015 Dec; 25():7-12. PubMed ID: 26414923
[TBL] [Abstract][Full Text] [Related]
15. Treatment of celiac disease: from gluten-free diet to novel therapies.
Francavilla R; Cristofori F; Stella M; Borrelli G; Naspi G; Castellaneta S
Minerva Pediatr; 2014 Oct; 66(5):501-16. PubMed ID: 24938882
[TBL] [Abstract][Full Text] [Related]
16. New Insights into Non-Dietary Treatment in Celiac Disease: Emerging Therapeutic Options.
Segura V; Ruiz-Carnicer Á; Sousa C; Moreno ML
Nutrients; 2021 Jun; 13(7):. PubMed ID: 34201435
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in the development of new treatments for celiac disease.
Lähdeaho ML; Lindfors K; Airaksinen L; Kaukinen K; Mäki M
Expert Opin Biol Ther; 2012 Dec; 12(12):1589-600. PubMed ID: 22928821
[TBL] [Abstract][Full Text] [Related]
18. HLA-DQ-Gluten Tetramer Blood Test Accurately Identifies Patients With and Without Celiac Disease in Absence of Gluten Consumption.
Sarna VK; Lundin KEA; Mørkrid L; Qiao SW; Sollid LM; Christophersen A
Gastroenterology; 2018 Mar; 154(4):886-896.e6. PubMed ID: 29146521
[TBL] [Abstract][Full Text] [Related]
19. Celiac disease: risk assessment, diagnosis, and monitoring.
Setty M; Hormaza L; Guandalini S
Mol Diagn Ther; 2008; 12(5):289-98. PubMed ID: 18803427
[TBL] [Abstract][Full Text] [Related]
20. Immunogenetic Pathogenesis of Celiac Disease and Non-celiac Gluten Sensitivity.
Escudero-Hernández C; Peña AS; Bernardo D
Curr Gastroenterol Rep; 2016 Jul; 18(7):36. PubMed ID: 27216895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
